← Leaderboards
Chaitanya R. Divgi
Sloan-Kettering Institute For Cancer Res
$3,132,169
Attributed
$3,132,169
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2.5M · FY2008–09$2.5M$1.9M$1.3M$625K$0
'08
'09
Funding mix
By agency
NIH$2,812,043 · 3
FDA$320,126 · 1
By mechanism
S10$2,000,000 · 1
R01$691,290 · 2
P01$440,879 · 1
Top collaborators
No co-investigators on record.
Most similar at Sloan-Kettering Institute For Cancer Res
Same institution · by research overlap
- Marcel R M Van Den Brink$40,856,878
- Jason A Koutcher$20,695,436
- David A Scheinberg$21,198,583
- Stewart H Shuman$39,945,088
- Michael J Morris$6,941,101
Others in their field
Top investigators on “Positron”
- Randall J Bateman · Washington University$160,794,656
- Paul S. Aisen · Cognition Therapeutics, Inc.$152,930,202
- Michael W Weiner · Northern California Institute Res &Educ$135,425,907
- Reisa A. Sperling · Banner Health$127,401,162
- Eric Martin McDade · Washington University$97,044,578
- Sid E O'Bryant · University Of North Texas Hlth Sci Ctr$82,263,855
Research focus
PositronProductionRadioisotopesClinical ResearchRadiotracerAntibodiesAdjuvant TherapyComplexColonAntigensAutoradiographyBacteriophagesBaseBinding (Molecular Function)Colon CarcinomaBiopsyAffinityClinical TrialsBismuthBlood CirculationAntitumor AntibodyChimeric ProteinsClinicBiodistribution
Grant awards (6)
Novel Antigen-Binding Constructs in Colorectal Cancer$287,158
P01 · FY2009 · CA · contact PI
Cyclotron for biomedical research$2,000,000
S10 · FY2008 · RR · contact PI
Utility of [F-18] fluoroDOPA for neonatal hyperinsulism: A Phase II$320,126
R01 · FY2008 · FD · contact PI
Novel Antigen-Binding Constructs in Colorectal Cancer$153,721
P01 · FY2008 · CA · contact PI
INTRAPERITONEAL RADIOIMMUNOTHERAPY FOR OVARIAN CANCER$144,655
R01 · FY2001 · CA
INTRAPERITONEAL RADIOIMMUNOTHERAPY FOR OVARIAN CANCER$226,509
R01 · FY2000 · CA